Soleno Therapeutics

Soleno Therapeutics

SLNO

Reported
Thursday, February 27

Q4 2024 Earnings

(USD)ExpectedReportedSurprise $Surprise %
EPS-0.64-1.27-0.63-98.44%
Revenue-0.00--
WhatIF - Earnings
EPS Missed Expectations by -$0.63
emptyImageAlt
Soleno Therapeutics (SLNO:NASDAQ) has never missed EPS by this much before
There’s a first time for everything